Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.
Value-based agreements (VBAs), Managed Entry Agreements (MEAs) or Outcomes-based agreements are arrangements between manufacturers and healthcare payers that allow for coverage of innovative treatments while managing uncertainty around financial impact or performance. VBAs are utilized to address payer concerns about the product's clinical value.
Over the past decade, much has been learned about the application of MEAs, including how to structure and assess their impact from the perspective of relevant stakeholders (manufacturers, payers, patients).
Experts present an evidence-based summary of global experience with Managed Entry Agreements, Outcomes-based Agreements, and Risk-sharing Arrangements. Common challenges, actionable solutions, and key learnings are discussed using case studies and multiple examples.
You'll learn about how a value-based agreement announced between Prime Therapeutics and Pear Therapeutics is being utilized to support coverage of prescription digital therapeutics for substance and opioid use disorder, including stakeholder incentive alignment and financing considerations. Mike Pace, former Global Commercial Head of Market Access and HEOR of Pear Therapeutics presents this case study and its broader implications.
Pierre Etienne and Clifton Chow describe how to define, measure, and monitor relevant outcomes as part of MEAs, with multiple examples from the literature.
At the end of this webinar, you will have a strong understanding of the types of financial and outcomes-based arrangements commonly utilized in the industry, including common pitfalls and possible solutions that drive success for the manufacturer, payer, and patient.
Presenters
Pierre Etienne
Dr. Pierre Etienne is a well-recognized thought leader and scientist, with strong research as well as business acumen; extensive experience both in the pharma industry and in academia, research, and clinical practice.
Michael Pace
Michael Pace, Founder & President, PalmHealth.co has carved a record of global health technology commercial growth at the intersection of biotechnology, chemical engineering, software development and value-based healthcare.
Clifton Chow
Dr. Clifton Chow is a health economist and policy analyst with over 20 years of health economic outcomes research (HEOR) experience. Prior to joining Actu-Real, he had been a director of HEOR with consulting firms that produced economic models, systematic literature reviews, and value dossier submissions for biotech and pharmaceutical clients.
Sponsor
Actu-Real
Content Partners
HealthEconomics.com
HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.
HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.
Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.
